Section 15-851 - Prior authorization for drug products to treat opioid use disorder - Prohibition(a)(1) This section applies to: (i) insurers and nonprofit health service plans that provide coverage for substance use disorder benefits or prescription drugs under individual, group, or blanket health insurance policies or contracts that are issued or delivered in the State; and(ii) health maintenance organizations that provide coverage for substance use disorder benefits or prescription drugs under individual or group contracts that are issued or delivered in the State.(2) An insurer, a nonprofit health service plan, or a health maintenance organization that provides coverage for substance use disorder benefits under the medical benefit or for prescription drugs through a pharmacy benefits manager is subject to the requirements of this section.(b) An entity subject to this section may not apply a prior authorization requirement for a prescription drug: (1) when used for treatment of an opioid use disorder; and(2) that contains methadone, buprenorphine, or naltrexone.Brought forward without change, 2024 Md. Laws, Ch. 848,Sec. 1, eff. 1/1/2025.Brought forward without change, 2024 Md. Laws, Ch. 847,Sec. 1, eff. 1/1/2025.Added by 2017 Md. Laws, Ch. 581, Sec. 1, eff. 5/25/2017.